These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30340764)

  • 1. Potential epigenetic therapeutics for atherosclerosis treatment.
    Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
    Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulatory Mechanisms Induced by Resveratrol.
    Fernandes GFS; Silva GDB; Pavan AR; Chiba DE; Chin CM; Dos Santos JL
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29104258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic mechanisms and their possible role in abdominal aortic aneurysm.
    Krishna SM; Dear AE; Norman PE; Golledge J
    Atherosclerosis; 2010 Sep; 212(1):16-29. PubMed ID: 20347091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches on epigenetics.
    Papait R; Monti E; Bonapace IM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs targeting epigenetic histone acetylation in vascular smooth muscle cells for restenosis and atherosclerosis.
    Natarajan R
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):725-7. PubMed ID: 21411753
    [No Abstract]   [Full Text] [Related]  

  • 8. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
    Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
    Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of chromatin remodeling agents for lung cancer therapy.
    Schrump DS; Hong JA; Nguyen DM
    Cancer J; 2007; 13(1):56-64. PubMed ID: 17464247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting epigenetic DNA and histone modifications to treat kidney disease.
    Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
    Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
    Schneider-Stock R; Ocker M
    IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between epigenetic mechanisms and transcription factors in atherosclerosis.
    Aziz M; Jandeleit-Dahm KA; Khan AW
    Atherosclerosis; 2024 Aug; 395():117615. PubMed ID: 38917706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role of epigenetic therapy in multiple myeloma.
    Smith EM; Boyd K; Davies FE
    Br J Haematol; 2010 Mar; 148(5):702-13. PubMed ID: 19912222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional Selectivity of Epigenetic Therapy in Cancer.
    Sato T; Cesaroni M; Chung W; Panjarian S; Tran A; Madzo J; Okamoto Y; Zhang H; Chen X; Jelinek J; Issa JJ
    Cancer Res; 2017 Jan; 77(2):470-481. PubMed ID: 27879268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos.
    Saini M; Selokar NL; Agrawal H; Singla SK; Chauhan MS; Manik RS; Palta P
    Reprod Fertil Dev; 2016 Apr; 28(6):824-37. PubMed ID: 25409339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review-Epigenetic therapy for cancer.
    Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI
    Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic small molecule modulators of histone and DNA methylation.
    Hauser AT; Robaa D; Jung M
    Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching on epigenetic therapy.
    Karberg S
    Cell; 2009 Dec; 139(6):1029-31. PubMed ID: 20005793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.